These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 16880237

  • 1. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO, de Castro C.
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [Abstract] [Full Text] [Related]

  • 2. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M, Machaczka M, Załuska A, Skotnicki AB.
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [Abstract] [Full Text] [Related]

  • 3. Hairy cell leukemia: current concepts.
    Cannon T, Mobarek D, Wegge J, Tabbara IA.
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [Abstract] [Full Text] [Related]

  • 4. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T.
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
    Hensel M, Ho AD.
    Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
    [Abstract] [Full Text] [Related]

  • 6. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D.
    Cancer; 2005 Dec 01; 104(11):2442-8. PubMed ID: 16245328
    [Abstract] [Full Text] [Related]

  • 7. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Dec 01; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W, Weltermann A, Chott A, Gisslinger H, Valent P, Jäger U, Geissler K, Lechner K.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1027-30. PubMed ID: 10677889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cladribine in hairy cell leukemia.
    Belani R, Saven A.
    Hematol Oncol Clin North Am; 2006 Oct 23; 20(5):1109-23. PubMed ID: 16990111
    [Abstract] [Full Text] [Related]

  • 13. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
    Chrobák L, Podzimek K, Zak P, Plísková L, Voglová J.
    Acta Haematol Pol; 1995 Oct 23; 26(2 Suppl 1):56-62. PubMed ID: 7653236
    [Abstract] [Full Text] [Related]

  • 14. Treatment of hairy-cell leukemia: current views.
    Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A.
    Semin Hematol; 1999 Apr 23; 36(2):155-63. PubMed ID: 10319384
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
    Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M.
    Eur J Haematol; 2004 Dec 23; 73(6):412-7. PubMed ID: 15522063
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.